Fosun Pharma Announces 2025 Interim Results
- Written by PR Newswire
Enhancing Innovation Efficiency and Steadily Expanding Globally
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its operating performance for the first half of...













